Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CCR1 | P32246 | 2/20 | 0.41 |
| ▸ | CCR5 | P51681 | 2/20 | 0.41 |
| ▸ | CCR8 | P51685 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
| ▸ | GABRD | O14764 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450081 | 1.00 | PARP1 (0.42) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL54128 | 0.77 | ALK (0.60) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL29433226 | 0.77 | ALK (0.60) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL8539662 | 0.77 | ALK (0.60) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL29351452 | 0.77 | ALK (0.60) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL28113431 | 0.76 | ALK (0.59) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL28348267 | 0.74 | ALK (0.56) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL13620452 | 0.73 | CCR1 (0.58) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| Quinmerac SCHEMBL5267957 | 0.72 | ALK (0.55) | PARP1CCR1CCR5CCR8ALDH1A1 | |
| SCHEMBL10595696 | 0.72 | MEN1 (0.47) | PARP1ALDH1A1SMN1; SMN2KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| US-20240199653-A1 | METHOD FOR FORMING AN ELECTRICALLY CONDUCTIVE METAL ORGANIC FRAMEWORK COMPOSITE | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2024-06-20 | — | — | US | claimed |
| WO-2024123903-A1 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | GE INFRASTRUCTURE TECHNOLOGY LLC (US) | 2024-06-13 | — | — | WO | claimed |
| WO-2024039914-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-02-22 | — | — | WO | claimed |
| US-20200291045-A1 | CONDUCTIVITY ENHANCEMENT OF MOFS VIA DEVELOPMENT OF MOFPOLYMER COMPOSITE MATERIAL | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2020-09-17 | — | — | US | claimed |
| EP-2739169-B1 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INST TECHNOLOGY (US) | 2019-06-12 | — | — | EP | claimed |
| US-20140311507-A1 | Porous Catalytic Matrices for Elimination of Toxicants Found in Tobacco Combustion Products | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2014-10-23 | — | — | US | claimed |
| EP-2739169-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | Massachusetts Institute Of Technology (US) | 2014-06-11 | — | — | EP | claimed |
| WO-2013019865-A2 | POROUS CATALYTIC MATRICES FOR ELIMINATION OF TOXICANTS FOUND IN TOBACCO COMBUSTION PRODUCTS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2013-02-07 | — | — | WO | claimed |
| US-20260138938-A1 | SEPARATION METHOD | DAIKIN INDUSTRIES, LTD. (JP) | 2026-05-21 | — | — | US | disclosed |
| WO-2026102259-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | MOSAIC MATERIALS, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| US-20260131275-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | MOSAIC MAT INC (US) | 2026-05-14 | — | — | US | disclosed |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | disclosed |
| US-20060210458-A1 | bringing the liquid into contact with at least one sorbent comprising a porous metal-organic framework, the framework taking up the liquid and comprising at least one at least bidentate organic compound having a coordinate bond to at least one metal ion | BASF AKTIENGESELLSCHAFT (DE) | 2006-09-21 | — | — | US | disclosed |
| EP-1687462-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005068474-A1 | ORGANOMETALLIC FRAMEWORK MATERIAL, PREPARATION AND USE | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-28 | — | — | WO | disclosed |
| US-20050154222-A1 | Process for preparing an organometallic framework material | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-14 | — | — | US | disclosed |
| WO-2005049892-A1 | METHOD FOR ELECTROCHEMICAL PRODUCTION OF A CRYSTALLINE POROUS METAL ORGANIC SKELETON MATERIAL | BASF AKTIENGESELLSCHAFT (DE) | 2005-06-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260131275-A1 | SYSTEM AND METHOD FOR TARGETED GAS DESORPTION FROM SORBENTS VIA AN EDUCTOR PUMP MECHANISM | EXOSC9, EXOSC4, EXOSC5 | PARP1 4868/4885CCR1 2396/4885CCR5 2036/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | PARP1 3344/4885CCR1 1390/4885CCR5 1090/4885 |
| US-20260138938-A1 | SEPARATION METHOD | DCX, FGB, TPR | PARP1 581/4885CCR1 1164/4885CCR5 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.